RAMESH GIHWALA: Open Payments
NPI 1447200183 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66,072 in 211 payments from 13 companies in 2025. Trend: 2023 $121,355 · 2024 $154,704 · 2025 $66,072
Speaker / faculty: $59,854Food & beverage: $3,525Travel & lodging: $2,009Consulting: $460Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 55 | $44,296 |
| Vanda Pharmaceuticals Inc. | 35 | $15,088 |
| ABBVIE INC. | 32 | $4,999 |
| Neurocrine BioSciences, Inc. | 37 | $644 |
| E.R. Squibb & Sons, L.L.C. | 15 | $321 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $209 |
| Otsuka America Pharmaceutical, Inc. | 10 | $167 |
| Alkermes, Inc. | 7 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
Products named: UZEDY, FANAPT, AUSTEDO XR, VRAYLAR, INGREZZA, COBENFY, CAPLYTA, ARISTADA.
Industry payments across NC — which companies pay providers there.
